## BACKGROUND. Breast carcinoma commonly metastasizes to the skeleton in patients with advanced disease to cause bone destruction and the associated pain, hypercalcemia, fracture, and nerve-compression syndromes. In this scenario, the bone destruction is mediated by the osteoclast. Tumor-produced
Bone Metastases: Molecular Mechanisms and Novel Therapeutic Interventions
β Scribed by Dionysios J. Papachristou; Efthimia K. Basdra; Athanasios G. Papavassiliou
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 405 KB
- Volume
- 32
- Category
- Article
- ISSN
- 0198-6325
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
It has been long recognized that skeleton represents one of the most favored metastatic sites for common cancers like breast and prostate. During the last decade the molecular mechanisms that are responsible for the development of bone metastasis have been gradually illuminated. It appears that the bone microenvironment has a pivotal role in this process. Metastatic tumor cells interact with bone triggering a cascade of molecular events that produce osteolytic and/or osteoblastic phenomena. In this review, we summarize and discuss the most significant factors and signaling pathways implicated in bone colonization. Moreover, based on the recent literature and data, we foresee the need for designing novel agents that will efficiently disrupt these interactions among cancer cells and bone microenvironment, bringing hope for more effective treatments. Β© 2010 Wiley Periodicals, Inc. Med Res Rev, 32, No. 3, 611β636, 2012
π SIMILAR VOLUMES
Osteolytic and osteoblastic metastases are often the cause of considerable morbidity in patients with advanced prostate and breast carcinoma. Breast carcinoma metastasis to bone occurs because bone provides a favorable site for aggressive behavior of metastatic cancer cells. A vicious cycle arises b